D.E. Shaw & Co
MRNA icon

D.E. Shaw & Co’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$206M Buy
7,463,555
+1,827,404
+32% +$50.4M 0.15% 98
2025
Q1
$160M Buy
5,636,151
+3,867,436
+219% +$110M 0.14% 124
2024
Q4
$73.5M Buy
1,768,715
+1,509,591
+583% +$62.8M 0.05% 272
2024
Q3
$17.3M Buy
+259,124
New +$17.3M 0.01% 724
2024
Q2
Sell
-48,022
Closed -$5.12M 3369
2024
Q1
$5.12M Sell
48,022
-314,155
-87% -$33.5M ﹤0.01% 1270
2023
Q4
$36M Buy
362,177
+303,845
+521% +$30.2M 0.03% 353
2023
Q3
$6.03M Sell
58,332
-20,175
-26% -$2.08M 0.01% 1082
2023
Q2
$9.54M Sell
78,507
-189,573
-71% -$23M 0.01% 905
2023
Q1
$41.2M Sell
268,080
-298,928
-53% -$45.9M 0.04% 317
2022
Q4
$102M Buy
567,008
+294,842
+108% +$53M 0.11% 119
2022
Q3
$32.2M Buy
272,166
+245,352
+915% +$29M 0.04% 389
2022
Q2
$3.83M Sell
26,814
-1,227,130
-98% -$175M ﹤0.01% 1806
2022
Q1
$216M Buy
1,253,944
+240,949
+24% +$41.5M 0.2% 59
2021
Q4
$257M Buy
1,012,995
+259,232
+34% +$65.8M 0.21% 55
2021
Q3
$290M Sell
753,763
-920,545
-55% -$354M 0.26% 41
2021
Q2
$393M Buy
1,674,308
+1,616,152
+2,779% +$380M 0.34% 35
2021
Q1
$7.62M Sell
58,156
-3,051,745
-98% -$400M 0.01% 1145
2020
Q4
$325M Buy
3,109,901
+2,343,772
+306% +$245M 0.29% 42
2020
Q3
$54.2M Buy
766,129
+455,804
+147% +$32.2M 0.06% 293
2020
Q2
$19.9M Buy
310,325
+262,490
+549% +$16.9M 0.02% 576
2020
Q1
$1.43M Sell
47,835
-327,503
-87% -$9.81M ﹤0.01% 1682
2019
Q4
$7.34M Buy
+375,338
New +$7.34M 0.01% 993
2019
Q3
Sell
-25,128
Closed -$368K 2681
2019
Q2
$368K Buy
+25,128
New +$368K ﹤0.01% 2236